HAYWARD, Calif.–(BUSINESS WIRE)– #CancerTherapy–RefleXion® Medical, an external-beam theranostic oncology company, today announced initiation of the BIOGUIDE-X2 clinical study to expand indications for SCINTIX® biology-guided radiotherapy at Hackensack Meridian John Theurer Cancer Center, a research partner with Georgetown’s Lombardi Comprehensive Cancer Center, an NCI-designated comprehensive cancer center. The company also announced key updates from the Centers for Medicare and Medicaid (CMS) Services. Sta